Expertise in
9
conditions

Pierre Blanchard

Tübingen Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
Tübingen Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 

Overview

Pierre Blanchard practices practicing medicine in Tuebingen, Germany.

Mr. Blanchard is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Prostate Cancer, Laryngectomy, and Prostatectomy.

He is actively involved in clinical research, co-authoring 322 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Tübingen Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous Tumors
A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous Tumors
Enrollment Status: Recruiting
Publish Date: June 16, 2026
Intervention Type: Device
Study Phase: Not Applicable
A Phase III Trial of Risk-stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
A Phase III Trial of Risk-stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 19, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 3
A Multicenter Prospective Phase II Study of Postoperative Hypofractionated Stereotactic Body Radiotherapy (SBRT) in the Treatment of Early Stage Oropharyngeal and Oral Cavity Cancers With High Risk Margins.
A Multicenter Prospective Phase II Study of Postoperative Hypofractionated Stereotactic Body Radiotherapy (SBRT) in the Treatment of Early Stage Oropharyngeal and Oral Cavity Cancers With High Risk Margins.
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02
A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02
Enrollment Status: Completed
Publish Date: June 01, 2021
Intervention Type: Drug
Study Drug: Afatinib
Study Phase: Phase 3
View 3 Less Clinical Trials

322 Total Publications

How to optimise prostate SBRT: ESTRO clinical practice consensus recommendations.
How to optimise prostate SBRT: ESTRO clinical practice consensus recommendations.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 07, 2026

Frequently Asked Questions about Pierre Blanchard

Is Pierre Blanchard a top-rated expert for Nasopharyngeal Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Pierre Blanchard is classified as an Distinguished expert for Nasopharyngeal Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pierre Blanchard participate in research or clinical trials?

Yes. Pierre Blanchard has published 322 articles and abstracts on conditions like Nasopharyngeal Carcinoma. You can view a list of Pierre Blanchard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Blanchard's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile